Luxiq (Prestium Pharma, Inc.)
Welcome to the PulseAid listing for the Luxiq drug offered from Prestium Pharma, Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Prestium Pharma, Inc. |
| NON-PROPRIETARY NAME: | Betamethasone Valerate |
| SUBSTANCE NAME: | BETAMETHASONE VALERATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | AEROSOL, FOAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-10-16 |
| END MARKETING DATE: | 0000-00-00 |
Luxiq HUMAN PRESCRIPTION DRUG Details:
| Item Description | Luxiq from Prestium Pharma, Inc. |
| LABELER NAME: | Prestium Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.2(mg/g) |
| START MARKETING DATE: | 2009-10-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 40076-021_d1529ecd-dcb2-460b-9683-6013226a09e9 |
| PRODUCT NDC: | 40076-021 |
| APPLICATION NUMBER: | NDA020934 |
Other BETAMETHASONE VALERATE Pharmaceutical Manufacturers / Labelers:
